You are here: Industry Insights > Innovent

News List

Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients pharmafocusasia
February 19, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology .....
Innovent Announces First Patient Dosed in Anti-CD47 Trial americanpharmaceuticalreview
January 16, 2019
Innovent Biologics announced the first patient has been successfully dosed in a phase I clinical trial of anti-CD47 monoclonal antibody (IBI188) for patients with advanced malignancies....
Innovent buys Chinese rights to Incyte drugs for $40M upfront fiercebiotech
December 18, 2018
Innovent Biologics has bagged the Chinese rights to three clinical-phase oncology and hematology drugs in development at Incyte.
Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China pharmafocusasia
December 17, 2018
Innovent Biologics, Inc. and Incyte today announced that the companies, through their respective subsidiaries, have entered into a strategic collaboration agreement for .....
Innovent and Hutchison to test sintilimab and fruquintinib combination pharmaceutical-technology
December 03, 2018
Innovent Biologics (Suzhou) has entered into a global collaboration agreement to evaluate the safety of its sintilimab in combination with Hutchison MediPharma’s fruquintinib .....
Innovent secures funding worth $150M biospectrumasia
May 02, 2018
The proceeds will be used to speed up and expand the company's clinical programs.

Previous page 1 2 3 4 5 6 7 8 9 Next page